More Opthea Limited news
Opthea LimitedASX: OPT

Opthea Completes Enrollment in Phase 3 Clinical Program

May 27, 2024 at 10:56 PM EDT · Issued by Opthea Limited

Filed with ASX · May 27, 2024 at 10:56 PM EDT

On 6ix: 6ix.com/news/opthea-completes-enrollment-in-phase-3-clinical-program

Opthea Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Opthea Limited on 6ix

Story so far

  • Opthea Completes Enrollment in First Trial of SoziniberceptFeb 15, 2024
  • Opthea Presenting Clinical Data at ARVO 2022 Annual MeetingMay 2, 2022
  • Opthea opens patient enrollment in the Asia-Pacifi RegionOct 20, 2021

Earlier from Opthea

  • Opthea Corporate Presentation - April 2024Apr 4, 2024
  • Opthea Key Opinion Leader Even on SoziniberceptApr 3, 2024
  • Opthea Corporate Presentation - March 2024Mar 4, 2024
  • Half Yearly Report and AccountsFeb 28, 2024
  • Opthea Reports Half-Year Results and Business UpdateFeb 28, 2024

Later from Opthea

  • Opthea to Present at Clinical Trials at the Summit MeetingJun 2, 2024
  • Trading Halt - Accelerated OfferJun 11, 2024
  • Opthea Annouces Equity RaiseJun 12, 2024
  • Opthea Equity Raise Investor PresentationJun 12, 2024
  • Opthea - Prospectus 2024Jun 12, 2024
All Opthea news releases↗

Follow Opthea into a list and get an email when it puts out news.

Follow Opthea
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer